Multiple Assemblies exist for SMTL entry 3e8e
Crystal structures of the kinase domain of PKA in complex with ATP-competitive inhibitors; X-RAY DIFFRACTION 2.00 Å

	SMTL ID 3e8e.1 Ligands 4-[2-(4-amino-2,5-dihydro-1,2,5-oxadiazol-3-yl)-6-{[(1S)-3-amino-1-phenylpropyl]oxy}-1-ethyl-1H-imidazo[4,5-c]pyridin-4-yl]-2-methylbut-3-yn-2-ol Polypeptides cAMP-dependent protein kinase catalytic subunit alpha; PKI inhibitor peptide Oligo-state hetero-1-1-mer
	SMTL ID 3e8e.2 Ligands 4-[2-(4-amino-2,5-dihydro-1,2,5-oxadiazol-3-yl)-6-{[(1S)-3-amino-1-phenylpropyl]oxy}-1-ethyl-1H-imidazo[4,5-c]pyridin-4-yl]-2-methylbut-3-yn-2-ol Polypeptides cAMP-dependent protein kinase catalytic subunit alpha; PKI inhibitor peptide Oligo-state hetero-1-1-mer
	SMTL ID 3e8e.3 Ligands 4-[2-(4-amino-2,5-dihydro-1,2,5-oxadiazol-3-yl)-6-{[(1S)-3-amino-1-phenylpropyl]oxy}-1-ethyl-1H-imidazo[4,5-c]pyridin-4-yl]-2-methylbut-3-yn-2-ol Polypeptides cAMP-dependent protein kinase catalytic subunit alpha; PKI inhibitor peptide Oligo-state hetero-1-1-mer
	SMTL ID 3e8e.4 Ligands 4-[2-(4-amino-2,5-dihydro-1,2,5-oxadiazol-3-yl)-6-{[(1S)-3-amino-1-phenylpropyl]oxy}-1-ethyl-1H-imidazo[4,5-c]pyridin-4-yl]-2-methylbut-3-yn-2-ol Polypeptides cAMP-dependent protein kinase catalytic subunit alpha; PKI inhibitor peptide Oligo-state hetero-1-1-mer
	SMTL ID 3e8e.5 Ligands 4-[2-(4-amino-2,5-dihydro-1,2,5-oxadiazol-3-yl)-6-{[(1S)-3-amino-1-phenylpropyl]oxy}-1-ethyl-1H-imidazo[4,5-c]pyridin-4-yl]-2-methylbut-3-yn-2-ol Polypeptides cAMP-dependent protein kinase catalytic subunit alpha; PKI inhibitor peptide Oligo-state hetero-1-1-mer
	SMTL ID 3e8e.6 Ligands 4-[2-(4-amino-2,5-dihydro-1,2,5-oxadiazol-3-yl)-6-{[(1S)-3-amino-1-phenylpropyl]oxy}-1-ethyl-1H-imidazo[4,5-c]pyridin-4-yl]-2-methylbut-3-yn-2-ol Polypeptides cAMP-dependent protein kinase catalytic subunit alpha; PKI inhibitor peptide Oligo-state hetero-1-1-mer